Month: April 2022

Apr 28 2022

Uncategorized

Everything You Need to Know About Schizophrenia In Kids

by Clinical Editor

No Comments

While schizophrenia is relatively uncommon in teens, young adults can be diagnosed. Here’s everything you need to know about this mental health condition.

Apr 28 2022

Uncategorized

Schizophrenia: The Recovery Process

by Clinical Editor

No Comments

Recovery from schizophrenia can be a slow process. However, it is important to never give up and always strive for wellness and a better life. I have been in full...

Apr 28 2022

Uncategorized

The Consequences of Stigma Surrounding Schizophrenia

by Clinical Editor

No Comments

As those of us who live with the diagnosis know, schizophrenia is a difficult condition to relate to. Most people can sympathize with someone who is suffering from an evident...

Apr 28 2022

Uncategorized

I Knew Someone With Schizophrenia, Here’s What Society Needs To Learn About Mental Illness

by Clinical Editor

No Comments

The good old consensus in Indian society would like you to believe that there exists nothing like a mental illness, giving way to indifference and stigma directed towards those with...

Apr 28 2022

Uncategorized

Health Canada Approves VRAYLAR® (cariprazine) for the Treatment of Bipolar l Disorder and Schizophrenia in Adults

by Clinical Editor

No Comments

AbbVie (NYSE: ABBV), a global, research and development-based biopharmaceutical company announced today that Health Canada has approved VRAYLAR® (cariprazine) as monotherapy for the acute management …

Apr 28 2022

Uncategorized

Risk of psychotic-like experiences can start in childhood

by Clinical Editor

No Comments

Researchers have found that the more urban of an environment a child lived in — proximity to roads, houses with lead paint risks, families in poverty, and income disparity —...

Apr 27 2022

Uncategorized

AbbVie’s Vraylar gets approval in Canada to treat bipolar 1, schizophrenia in adults

by Clinical Editor

No Comments

AbbVie (ABBV) said Health Canada approved Vraylar (cariprazine) as a standalone therapy for the acute management of manic, mixed, and depressive episodes linked with bipolar 1 …

Apr 27 2022

Uncategorized

Health Canada Approves VRAYLAR® (cariprazine) for the Treatment of Bipolar l Disorder and Schizophrenia in Adults

by Clinical Editor

No Comments

AbbVie (NYSE: ABBV), a global, research and development-based biopharmaceutical company announced today that Health Canada has approved VRAYLAR® (cariprazine) as monotherapy for the acute management …

Apr 27 2022

Uncategorized

Schizophrenia: The Recovery Process

by Clinical Editor

No Comments

Recovery from schizophrenia can be a slow process. However, it is important to never give up and always strive for wellness and a better life. I have been in full...

Apr 27 2022

Uncategorized

I Knew Someone With Schizophrenia, Here’s What Society Needs To Learn About Mental Illness

by Clinical Editor

No Comments

The good old consensus in Indian society would like you to believe that there exists nothing like a mental illness, giving way to indifference and stigma directed towards those with...